Large Cap · Healthcare · Healthcare Plans
Large Cap · Healthcare · Healthcare Plans
Get the AI take on ELV
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
52/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$393
Current price
$401.36
Median target
$457
Highest
$492
Forward P/E
Favorable · 27% below avg
14.78x
Price / sales
Strong · Priced modestly against the revenue it brings in
0.43x
Price / FCF
Strong · Priced well within what its cash flow supports
13.80x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
12.93x
ROIC
Reasonable · A middling return on the capital it puts to work
8.5%
ROE
Middle ground · Mixed
11.1%
Debt / equity
Favorable · 0.73 - solid leverage
0.69x
Current ratio
Strong · Comfortable room to cover bills due within a year
1.52x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $86.82B | 17.8 | +6.3% | 52 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |